Table 1.
Physical and Biochemical Characteristics in the Study Subjects
| Variable |
Control n = 10 |
Angina n = 15 |
CABG n = 10 |
| Age (years) | 62 ± 13 | 64 ± 13 | 70 ± 5 |
| Smokers | 2 | 4 | 1 |
| SBP (mmHg) | 125 ± 9 | 142 ± 15* | 140 ± 14* |
| DBP (mmHg) | 72 ± 8 | 76 ± 9 | 78 ± 12 |
| Total cholesterol (mg/dl) | 4.9 ± 1.6 | 5.3 ± 1.2 | 4.4 ± 2.4 |
| LDL (mg/dl) | 3.5 ± 0.7 | 3.5 ± 1.1 | 2.5 ± 1.6 |
| HDL (mg/dl) | 1.5 ± 0.5 | 1.5 ± 0.4 | 1.3 ± 0.5 |
| Triglycerides (mg/dl) | 1.5 ± 0.9 | 1.7 ± 1.0 | 1.9 ± 0.9 |
| Apo lipoprotein A (mg/dl) | 1.5 ± 0.3 | 1.6 ± 0.2 | 1.3 ± 0.5 |
| Apo lipoprotein B (mg/dl) | 0.9 ± 0.2 | 1.0 ± 0.3 | 0.9 ± 0.3 |
| NYHA class | |||
| I | 10 | 10 | 4 |
| II | 0 | 0 | 4 |
| III | 0 | 0 | 2 |
| IV | 0 | 0 | 0 |
| NT pro-BNP (ng/L) | 106 ± 112 | 218 ± 243 | 1626 ± 2157* |
| C reactive protein (mg/dl) | 2.1 ± 1.9 | 6.2 ± 15.3* | 6.9 ± 6.1* |
| Beta blockers (n) | 0 | 6 | 7 |
| Statins (n) | 0 | 5 | 8 |
| ARB or ACEI (n) | 0 | 3 | 6 |
| HbA1c (%) | 4.5 ± 0.5 | 4.7 ± 0.4 | 4.7 ± 0.8 |
| BMI (kg/m2) | 28 ± 2 | 29 ± 5 | 27 ± 3 |
Values are expressed as mean ± SD. Statistical analysis was performed using ANOVA with Dunnet's post-test for multiple comparisons. Significance was defined as P < 0.05 (*). Abbreviations are: CABG, coronary artery bypass graft surgery; SBP, systolic blood pressure; DBP, diastolic blood pressure; LDL, low-density lipoprotein cholesterol; HDL, high-density lipoprotein cholesterol; NYHA, New York Heart Association Functional Classification; NT-proBNP, N-terminal pro B-type natriuretic peptide; ARB, angiotensin receptor blockers; ACEI, angiotensin converting enzyme inhibitors and BMI, body mass index.